Somatic Symptom Disorder
Conditions
Interventions
None listed
Sponsors
Universiteit van Tilburg
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients with SSD: participants (age 18 -65 years) should suffer from medically unexplained somatic symptoms (MUSS) (e.g. chronic somatic unexplained headaches, chronic fatigue syndrome, unexplained dizziness, whiplash-related complaints, fibromyalgia and irritable bowel syndrome) with no or insufficient medical explanation.
Exclusion criteria
Exclusion criteria: MUSS symptoms present for less than 6 months, another psychiatric disorder as main classification, age 65, insufficient mastery of the Dutch language, and unregistered drug or alcohol abuse. Comorbidity and use of psychopharmaceuticals Patients who agree to participate in the MRI study will be screened for MRI contraindications. Contraindications are metal implants or other metal objects that can not be removed, (possible) pregnancy, and claustrophobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study predicts a beneficial effect of DIT therapy on several parameters: - Compared to a waiting list group, subjects show an increase in mentalization (about oneself and others), a decrease in levels of stress, pain and fatigue, functional disability. - Associations between childhood trauma and brain structure and function are expected. We expect that structural and functional brain abnormalities realted to trauma play a role in SSD symptoms and that DIT treatment may reverse these abnormalities. | — |
Secondary
| Measure | Time frame |
|---|---|
| we will examine the role of possible moderators in the effect of DIT: childhood trauma, attachment, comorbidity. | — |
Countries
Netherlands
Outcome results
None listed